A Randomized, Double-blind, Crossover Study to Compare the Pharmacokinetic and Pharmacodynamic Bioequivalence of a Single Injection of MSB11455 and Neulasta in Healthy Adult Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Pegfilgrastim (Primary)
- Indications Neutropenia; Radiation injuries
- Focus Pharmacokinetics
- Sponsors Merck KGaA
- 13 Mar 2018 Planned End Date changed from 31 Oct 2018 to 9 Apr 2018.
- 13 Mar 2018 Planned primary completion date changed from 31 Oct 2018 to 9 Apr 2018.
- 13 Mar 2018 Status changed from recruiting to active, no longer recruiting.